Analytical Data
-
基因名
vsdF
- Application
-
种属
Salmonella dublin
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P24421
-
表达区间
1-119aa
-
分子量
26.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VsdF, a novel protein identified in various bacterial species, has garnered significant attention in recent years due to its potential applications in biotechnology and medicine. Originally discovered through genomic studies, VsdF exhibits unique structural and functional properties, distinguishing it from other known proteins. Its role in bacterial metabolism and stress responses raises questions about its mechanisms of action and evolutionary significance. Researchers are particularly interested in VsdF's potential to act as a biomarker for bacterial infections and its utility in the development of new therapeutic agents. Additionally, the recombinant production of VsdF in heterologous systems, such as E. coli, has enabled detailed biochemical studies and functional assays, providing insights into its biological activity. The ongoing exploration of VsdF's interactions with other cellular components and its regulatory pathways may reveal novel targets for antibiotic development. As the prevalence of antibiotic-resistant bacteria escalates, understanding proteins like VsdF becomes crucial in shaping future treatment strategies. The unique features of VsdF underscore its promise as a candidate for further investigation, driving ongoing research into its characterization and application in addressing contemporary challenges in infectious disease control and therapeutic interventions.
